Log In
Print
BCIQ
Print
Print this Print this
 

Berinert, Berinert P (C1-INH concentrate)

  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
DescriptionPlasma-derived human complement 1 (C1) esterase inhibitor
Molecular Target Complement 1 (C1) esterase
Mechanism of ActionComplement inhibitor
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationAngioedema
Indication DetailsTreat acute attacks of hereditary angioedema (HAE); Treat hereditary angioedema (HAE); Treat pre-procedure prevention of acute attacks of hereditary angioedema (HAE)
Regulatory Designation

U.S. - Priority Review (Treat hereditary angioedema (HAE))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today